Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.875
+0.015 (0.81%)
At close: Sep 18, 2026, 4:00 PM EDT
1.922
+0.046 (2.48%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Cardiol Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
18
Market Cap
217.66M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 78.76K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Emergent BioSolutions | 770.20M |
| Organogenesis Holdings | 457.45M |
| Aurora Cannabis | 221.16M |
| Akebia Therapeutics | 219.06M |
| Organigram Global | 217.71M |
| Lifecore Biomedical | 129.46M |
| Anika Therapeutics | 120.65M |
| ADC Therapeutics | 79.58M |
CRDL News
- 2 days ago - Cardiol Therapeutics (CRDL) Raises $7M via Warrants, Extends Runway into 2028 - GuruFocus
- 2 days ago - Cardiol Therapeutics Registration statement: Registration filing - Filings
- 2 days ago - Cardiol Therapeutics receives over $7M in proceeds from warrant exercise - TheFly
- 2 days ago - Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds - PRNewsWire
- 4 days ago - Cardiol Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 8 days ago - Cardiol Therapeutics files $150M preliminary base shelf prospectus - TheFly
- 8 days ago - Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission - PRNewsWire
- 8 days ago - Cardiol Therapeutics Registration statement: Registration filing - Filings